Toronto Dominion Bank Acquires 2,086 Shares of Waters Co. (NYSE:WAT)

Toronto Dominion Bank raised its holdings in Waters Co. (NYSE:WAT) by 8.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 26,234 shares of the medical instruments supplier’s stock after purchasing an additional 2,086 shares during the quarter. Toronto Dominion Bank’s holdings in Waters were worth $7,611,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of WAT. Foguth Wealth Management LLC. acquired a new position in shares of Waters during the first quarter worth approximately $2,773,000. Virtu Financial LLC bought a new position in Waters in the 4th quarter valued at $962,000. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH increased its stake in shares of Waters by 2,134.3% in the 1st quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 5,921 shares of the medical instruments supplier’s stock valued at $2,038,000 after buying an additional 5,656 shares during the period. Vanguard Group Inc. raised its position in shares of Waters by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 6,837,662 shares of the medical instruments supplier’s stock worth $2,251,163,000 after acquiring an additional 64,525 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Waters by 223.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 8,222 shares of the medical instruments supplier’s stock valued at $2,707,000 after acquiring an additional 5,683 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Analyst Ratings Changes

WAT has been the subject of a number of research reports. Wells Fargo & Company started coverage on Waters in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $380.00 price objective for the company. Evercore ISI lowered their price target on shares of Waters from $320.00 to $300.00 and set an “in-line” rating for the company in a research report on Tuesday, July 2nd. Leerink Partnrs upgraded shares of Waters from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 1st. The Goldman Sachs Group raised shares of Waters to a “hold” rating in a report on Wednesday, July 31st. Finally, Barclays increased their price target on Waters from $275.00 to $300.00 and gave the company an “underweight” rating in a research note on Thursday, August 1st. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Waters presently has an average rating of “Hold” and a consensus target price of $322.00.

Waters Stock Performance

Shares of Waters stock opened at $357.33 on Friday. Waters Co. has a 12 month low of $231.90 and a 12 month high of $367.21. The company has a current ratio of 2.10, a quick ratio of 1.42 and a debt-to-equity ratio of 1.42. The company has a market capitalization of $21.21 billion, a PE ratio of 35.07, a PEG ratio of 5.96 and a beta of 0.95. The stock’s fifty day simple moving average is $333.53 and its 200 day simple moving average is $324.14.

Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $2.63 earnings per share for the quarter, beating the consensus estimate of $2.55 by $0.08. Waters had a return on equity of 56.81% and a net margin of 20.71%. The business had revenue of $709.00 million for the quarter, compared to analysts’ expectations of $700.09 million. During the same quarter in the previous year, the business posted $2.80 EPS. Waters’s revenue for the quarter was down 4.3% on a year-over-year basis. On average, research analysts predict that Waters Co. will post 11.6 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.